173 related articles for article (PubMed ID: 3259672)
61. [Circulating immune complexes, detection in human glomerulonephritis by the PEG-EDTA technique (author's transl)].
Laurent B; Gonthier R; Genin C; Toulon J; Laurent P; Sabatier JC; Berthoux FC
Pathol Biol (Paris); 1982 Mar; 30(3):141-6. PubMed ID: 6808442
[TBL] [Abstract][Full Text] [Related]
62. Detection and quantitation of circulating immune complexes by the C1q-protein A binding assay (C1q-PABA).
Glikmann G; Svehag SE
Methods Enzymol; 1981; 74 Pt C():571-88. PubMed ID: 6798369
[No Abstract] [Full Text] [Related]
63. Kinetics of C1 activation by a monoclonal anti-C1q antibody and its (Fab)2 fragments.
Kilchherr E; Schumaker VN; Bianchino AC; Curtiss LK
J Immunol; 1987 Feb; 138(3):849-55. PubMed ID: 3492535
[TBL] [Abstract][Full Text] [Related]
64. Antigenic interspecies cross-reaction of subcomponent C1q of the first component of complement: evidence for its cross-reaction in both collagen-like and non-collagen-like regions.
Yonemasu K; Sasaki T; Shimizu A
J Biochem; 1983 Apr; 93(4):1079-84. PubMed ID: 6408070
[TBL] [Abstract][Full Text] [Related]
65. Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay.
Leatherbarrow RJ; Dwek RA
Mol Immunol; 1984 Apr; 21(4):321-7. PubMed ID: 6610105
[TBL] [Abstract][Full Text] [Related]
66. Anti-IgG binding test to assay circulating IgG-containing immune complexes from polyethylene glycol precipitates.
Levinson SS; Goldman JO; Feldkamp CS
Clin Chem; 1984 Sep; 30(9):1502-6. PubMed ID: 6235980
[TBL] [Abstract][Full Text] [Related]
67. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
Poulton TA; Mooney NA; Nineham LJ; Hay FC
Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
[TBL] [Abstract][Full Text] [Related]
68. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
Nydegger UE; Lambert PH; Gerber H; Miescher PA
J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
[TBL] [Abstract][Full Text] [Related]
69. [Clinical significances of circulating immune complexes in connective tissue diseases--detection by C1q deviation test, precipitin reaction of C1q in gel diffusion, anti-antibody inhibition test and precipitation with polyethylene glycol].
Yasuda M
Ryumachi; 1983 Oct; 23(5):315-26. PubMed ID: 6608796
[No Abstract] [Full Text] [Related]
70. Inhibition of immune complex-mediated activation of complement. Effects of agents modulating activation of, and the activated C1 complex.
Fletcher DS; Lin TY
Inflammation; 1980 Mar; 4(1):113-23. PubMed ID: 6967051
[TBL] [Abstract][Full Text] [Related]
71. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
72. C1q solid-phase radioimmunoassay: binding properties of solid-phase C1q and evidence that C1q-binding IgG complexes in systemic lupus erythematosus are not bound to endogenous C1q.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
J Immunol Methods; 1984 Oct; 73(1):67-74. PubMed ID: 6436382
[TBL] [Abstract][Full Text] [Related]
73. Co-operative interaction of subcomponents of the first component of complement with IgG: a functional defect of dimeric Facb from rabbit IgG.
Okada M; Udaka K; Utsumi S
Mol Immunol; 1985 Dec; 22(12):1399-406. PubMed ID: 3007976
[TBL] [Abstract][Full Text] [Related]
74. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
[TBL] [Abstract][Full Text] [Related]
75. C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.
Sim RB; Arlaud GJ; Colomb MG
Biochem J; 1979 Jun; 179(3):449-57. PubMed ID: 475762
[TBL] [Abstract][Full Text] [Related]
76. Nature of the interaction between the C1q and C1r2S2 subunits of the first component of human complement.
Ziccardi RJ
Mol Immunol; 1985 Apr; 22(4):489-94. PubMed ID: 2993872
[TBL] [Abstract][Full Text] [Related]
77. A method for rapid determination of IgG containing circulating immune complexes using polyethyleneglycol and radioactively labeled protein A.
Stevens WJ; Bridts C
Immunol Lett; 1981 Apr; 3(1):1-4. PubMed ID: 7024111
[TBL] [Abstract][Full Text] [Related]
78. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
[TBL] [Abstract][Full Text] [Related]
79. Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol.
Digeon M; Laver M; Riza J; Bach JF
J Immunol Methods; 1977; 16(2):165-83. PubMed ID: 881555
[TBL] [Abstract][Full Text] [Related]
80. A C1Q enzyme-linked immunosorbent assay (ELISA) using polyethylene glycol for immune complexes.
Lunde MN
Am J Trop Med Hyg; 1983 Mar; 32(2):392-6. PubMed ID: 6340543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
